Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CASP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ASMTL-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
LINC01521 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DHX30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUTM2B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPS8L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEA10-MAGEA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on